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Abstract
Genome-wide association studies have revealed a relationship between inter-individual variation in blood pressure and the
single nucleotide polymorphism rs13107325 in the SLC39A8 gene. This gene encodes the ZIP8 protein which co-transports di-
valent metal cations, including heavy metal cadmium, the accumulation of which has been associated with increased blood
pressure. The polymorphism results in two variants of ZIP8 with either an alanine (Ala) or a threonine (Thr) at residue 391.
We investigated the functional impact of this variant on protein conformation, cadmium transport, activation of signalling
pathways and cell viability in relation to blood pressure regulation. Following incubation with cadmium, higher intracellular
cadmium was detected in cultured human embryonic kidney cells (HEK293) expressing heterologous ZIP8-Ala391, compared
with HEK293 cells expressing heterologous ZIP8-Thr391. This Ala391-associated cadmium accumulation also increased the
phosphorylation of the signal transduction molecule ERK2, activation of the transcription factor NFjB, and reduced cell viabil-
ity. Similarly, vascular endothelial cells with the Ala/Ala genotype had higher intracellular cadmium concentration and lower
cell viability than their Ala/Thr counterpart following cadmium exposure. These results indicate that the ZIP8 Ala391-to-
Thr391 substitution has an effect on intracellular cadmium accumulation and cell toxicity, providing a potential mechanistic
explanation for the association of this genetic variant with blood pressure.
†These authors share the senior authorship
Received: April 15, 2016. Revised: June 13, 2016. Accepted: July 11, 2016
VC The Author 2016. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
4117
Human Molecular Genetics, 2016, Vol. 25, No. 18 4117–4126
doi: 10.1093/hmg/ddw236
Advance Access Publication Date: 27 July 2016
Association Studies Article
Introduction
High blood pressure (BP) is a major risk factor for many cardio-
vascular diseases. It is a multifactorial trait, with an estimated
heritability of 0.3–0.5 (1,2). Genome-wide association studies
(GWAS) have identified a number of genomic loci at which sin-
gle nucleotide polymorphisms (SNPs) are associated with inter-
individual variation in BP (3). Among them is SNP rs13107325 in
the SLC39A8 (solute carrier family 39 member 8, HGNC: 20862)
gene on chromosome 4q22, with its major allele associating
with increased systolic and diastolic BP (3). However, the molec-
ular and cellular mechanisms underlying its association with
BP are unknown.
rs13107325 is a non-synonymous SNP located in exon 8 of
SLC39A8, with the major allele having a cytosine (C) and the mi-
nor allele having a thymidine (T) at the first position of the co-
don for amino acid 391 (NC_000004.11:g.103188709C>T). Thus,
the protein, ZIP8, encoded by this gene can be either the Ala391
form (encoded by the C allele) or the Thr391 variant (encoded by
the T allele). ZIP8 is a plasma membrane transporter of metal
ions including cadmium (Cd2þ), zinc, manganese and iron (4,5).
It plays a key role in cellular uptake of Cd2þand in Cd2þ-induced
cytotoxicity (6,7). Cd2þexposure has been associated with the
development of high BP and other cardiovascular diseases (8–
13), which are likely to be the consequence of Cd2þ-induced
damage to the kidney and vascular endothelial cells (7,14–17),
both playing important roles in BP regulation.
In this study, we sought to investigate whether the BP-
associated SNP rs13107325 (Ala391Thr) has a functional effect
on ZIP8-mediated Cd2þ transport in human embryonic kidney
cells (HEK293) and human umbilical vascular endothelial cells
(HUVECs) and its subsequent influence on ERK1/2 and NFjB sig-
nalling pathways leading to Cd2þ-induced cytotoxicity.
Results
In silico structural and bioinformatic analyses
Conservation analysis revealed that the common allele C of
rs13107325 had been well conserved in 22 out of the 23 amniote
vertebrates as shown in the sequence alignment in Figure 1A,
suggesting that the C allele may be important in the preserva-
tion of protein function. ConSurf Server analysis also indicated
Ala391 residue being highly conserved and crucial for maintain-
ing protein fold predicted by Markov Model based algorithm
(normalized conservation score 9, structural residual) when
compared with 142 reference sequences (Figure 1B). An analysis
with TMHMM prediction suggested that the Ala391 residue was
packed inside the a-helical transmembrane domain of the ZIP8
protein, whereas the Thr391 residue was located just outside
the a-helix domain in the corresponding protein (Figure 1C).
This finding prompted further investigation by performing
homology-based 3D protein structure modelling using the
Robetta approach. Secondary structure analysis was performed
to predict in silico the effect of the Ala391-to-Thr391 substitution
on the structure and dynamics of ZIP8. This was performed on
both the ZIP8-Ala391 and ZIP8-Thr391-containing protein se-
quences. The analysis revealed a total of 7 a-helical domains for
both sequences. A noticeable change was observed at the a-heli-
cal structural transition (residues 390-392) in the ZIP8-Thr391
sequence when overlapped with the ZIP8-Ala391 sequence, to-
gether with other transmembrane a-helical domain in close
proximity shifting their position within the membrane
(Figure 1D).
Furthermore, the Sorting Tolerant From Intolerant (SIFT) (18)
and Polymorphism Phenotyping v2 (PolyPhen-2) (19) tools pre-
dicted that rs13107325 had a possibly damaging effect on pro-
tein function.
A research using the UCSC Genome Browser showed that
rs13107325 was located in a genomic region without evidence of
transcription factor binding, suggesting that it probably does
not affect gene transcription. Consistently, an allelic expression
imbalance assay of rs13107325 in HUVEC cells showed no differ-
ence in SLC39A8 RNA level between the C and T alleles
(Supplementary Material, Fig. S1).
Effect of SNP rs13107325 on Cd2þ intracellular
accumulation
To ascertain an effect of the ZIP8 Ala391-to-Thr391 substitution
on Cd2þ transport and intracellular accumulation, HEK293 kid-
ney cells were transfected with either the pcDNA-ZIP8-Ala391,
pcDNA-ZIP8-Thr391, or pcDNA3.1(þ) plasmid. The efficiency of
transfection and specificity of the antibody used for subsequent
immunoblotting analysis are shown in Supplementary Material,
Fig. S2. Transfected cells were incubated with Cd2þ (1lmol/l) or
vehicle (H2O) for 2 h, followed by measurement of intracellular
Cd2þ levels. A range of 1–10lmol/l of Cd2þhas generally been
used in the literature. The concentration of 1 lmol/l used in our
study is closer to the Km value of 0.62 lmol/l for ZIP8-mediated
Cd2þ transport in mouse foetal fibroblasts (4). Immunoblotting
analyses demonstrated that HEK293 cells transfected with ei-
ther the pcDNA-ZIP8-Ala391 or pcDNA-ZIP8-Thr391 plasmid
had a substantial increase in total ZIP8 protein level as com-
pared with cells transfected with the empty pcDNA3.1(þ) plas-
mid and that there was no significant difference in ZIP8 level
between cells transfected with either the pcDNA-ZIP8-Ala391
and those transfected pcDNA-ZIP8-Thr391 plasmid (Figure 2A).
Measurement of Cd2þ in the cell lysates showed that the
intracellular Cd2þconcentration was significantly higher in
HEK293 cells transfected with the pcDNA-ZIP8-Ala391 plasmid
than in those transfected with the pcDNA-ZIP8-Thr391
plasmid (Figure 2B), suggesting that the Ala391-to-Thr391 sub-
stitution has an effect on Cd2þ transport and intracellular
accumulation.
To investigate if the ZIP8 Ala391-to-Thr391 substitution af-
fected intracellular Cd2þaccumulation in vascular endothelial
cells, primary cultures of HUVECs of either the Ala/Ala or Ala/
Thr genotype were incubated with Cd2þ (1 lmol/l) for 2 h, fol-
lowed by measurement of Cd2þaccumulation in cell lysates
[due to the rarity of minor allele homozygotes, no HUVECs with
this genotype (Thr/Thr) were available for our study].
Immunoblotting analyses detected no significant difference in
ZIP8 level between HUVECs of the Ala/Ala genotype and
HUVECs of the Ala/Thr genotype (Figure 2C). Importantly,
Cd2þassays showed that HUVECs of the Ala/Ala genotype had
significantly higher intracellular Cd2þ levels than those of the
Ala/Thr genotype (Figure 2D), indicating that SNP rs13107325,
leading to the Ala391-to-Thr391 substitution, has an effect on
Cd2þaccumulation in vascular endothelial cells.
Effect of SNP rs13107325 on Cd2þ-induced cytotoxicity
Having found that the ZIP8 Ala391-to-Thr391 substitution af-
fected Cd2þ intracellular accumulation in kidney and endothelial
cells, we investigated if it had any influence on Cd2þ-induced
cytotoxicity. HEK293 cells transfected with either the pcDNA-
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ZIP8-Ala391, pcDNA-ZIP8-Thr391, or pcDNA3.1(þ) plasmid were
incubated with 1lmol/l Cd2þor vehicle (H2O) for 2 or 24 h, fol-
lowed by cytotoxicity assays. Assessment of cell morphology re-
vealed that following Cd2þ treatment, HEK293 cells transfected
with either the pcDNA-ZIP8-Ala391 or pcDNA-ZIP8-Thr391 plas-
mid became smaller and changed from spindle-shape to
spherical-shape, which were not observed in cells transfected
with the pcDNA3.1(þ) vector control (Figure 3A). Following
Cd2þ treatment for 2 h, the viability of cells expressing the heter-
ologous ZIP8-Ala391 was lower than that of cells expressing the
heterologous ZIP8-Thr391, and both had lower viability than cells
transfected with the vector control (Figure 3B). Correspondingly,
24 h exposure to 1lmol/l Cd2þresulted in larger amounts of LDH
released by dead cells in media conditioned by ZIP8-Ala391
expressing cells than in media conditioned by ZIP8-Thr391 ex-
pressing cells, and both had significantly higher LDH concentra-
tions compared with media conditioned by cells transfected with
the empty plasmid (Figure 3C).
To determine if the effect of the ZIP8 Ala391-to-Thr391 substi-
tution on Cd2þ-induced cytotoxicity also occurred in vascular en-
dothelial cells, HUVECs of either the C/C (Ala/Ala) or C/T (Ala/Thr)
genotype were incubated with Cd2þ (1lmol/l) for 24 h, followed
by measurement of LDH in culture media. Consistent with the
findings in HEK293 cells, media conditioned by HUVECs of
the Ala/Ala genotype had significantly higher LDH concentra-
tions than media conditioned by HUVECs of the Ala/Thr
genotype (Figure 3D), suggesting a genotype-specific Cd2þ cyto-
toxic effect.
Figure 1. Results of computational analyses of ZIP8 Ala391-to-Thr391. (A) A comparison of DNA sequences around the rs13107325 site in 23 mammals. (B) Output of
ConSurf Server analysis based on 142 reference sequences, the arrow points the amino acid position of Ala391. (C) Graphical interpretation of the transmembrane heli-
cal domains predicted by TMHMM. The number at the top denotes the amino acid position, the Ala391-to-Thr391 substitution is circled in pink, which locates outside
the cell membrane. (D) Structural perturbation induced by the Ala391-to-Thr391 substitution as shown by Robetta secondary protein structure prediction. The image
shows an overlapped simulation of the two proteins. The Thr391 residue (represented by the blue circle) is at a distance of 6 A˚ from the Ala391 residue (represented by
the yellow circle).
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Effect of SNP rs13107325 on Cd2þ-induced ERK1/2
phosphorylation
Since MAPK signalling pathway activation has been implicated in
Cd2þ-induced cytotoxicity (20), we investigated if the ZIP8 Ala391-
to-Thr391 substitution had any effect on this pathway in re-
sponse to Cd2þexposure. HEK293 cells transfected with either the
pcDNA-ZIP8-Ala391, pcDNA-ZIP8-Thr391, or pcDNA3.1(þ) plas-
mid were incubated with Cd2þ (1lmol/l) for 24 h, followed by im-
munoblot analyses of the amounts of total and phosphorylated
ERK1 and ERK2 in cell lysates. The analyses confirmed increased
ZIP8 expression of cells transfected with the pcDNA-ZIP8-Ala391
or pcDNA-ZIP8-Thr391 plasmid as compared with cells trans-
fected with the empty plasmid vector pcDNA3.1(þ), and showed
that there was no significant difference in ZIP8 level between cells
transfected with the pcDNA-ZIP8-Ala391 plasmid and those
transfected with the pcDNA-ZIP8-Thr391 plasmid (Figure 4A and
B). Following Cd2þ treatment, the levels of phospho-ERK1 and
phospho-ERK2 were higher in cells expressing heterologous ZIP8-
Ala or ZIP8-Thr391 than in cells transfected with the empty plas-
mid (Figure 4A,C and D). There was no significant difference in
the ratio of phospho-ERK1 versus total ERK1 between pcDNA-
ZIP8-Ala391 and pcDNA-ZIP8-Thr391 expressing cells (Figure. 4C).
However, the ratio of phospho-ERK2 versus total ERK2 in pcDNA-
ZIP8-Ala391 expressing cells was significantly higher than that in
pcDNA-ZIP8-Thr391 expressing cells, with standardization for
ZIP8 expression levels (Figure. 4D).
Effect of SNP rs13107325 on NFjB activation in
response to Cd2þ
Since NFŒB has also been implicated in Cd2þ-induced cytotoxic-
ity (20), we investigated whether the ZIP8 Ala391-to-Thr391 sub-
stitution had an effect on NFŒB activation. HEK293 cells were
transfected with either the pcDNA-ZIP8-Ala391, pcDNA-ZIP8-
Thr391, or pcDNA3.1(þ) plasmid, as well as a firefly luciferase
reporter plasmid and a renilla luciferase plasmid (the
latter to serve as a reference of transfection efficiency).
Immunoblot analyses showed no significant difference in ZIP8
level between cells transfected with the pcDNA-ZIP8-Ala391
plasmid and those transfected with the pcDNA-ZIP8-Thr391
plasmid. The transfected cells were incubated with Cd2þ for 2 h,
followed by dual-luciferase assays to measure NFjB activity.
The assays showed 5-10 fold higher NFjB activity in the ZIP8-
expressing cells than in cells transfected with the empty plas-
mid and a statistically significant 1.2 fold difference between
cells transfected with the pcDNA-ZIP8-Ala391 plasmid and
those transfected with the pcDNA-ZIP8-Thr391 plasmid
(Figure 5A).
Figure 2. Effect of ZIP8 Ala391-to-Thr391 on intracellular Cd2þaccumulation. (A) Immunoblotting analysis of HEK293 cells transfected with the pcDNA-ZIP8-Ala391, pcDNA-
ZIP8-Thr391, or pcDNA3.1(þ) plasmid, with an anti-ZIP8 antibody and an antibody for the loading control protein b-actin. Upper panel: a representative immunoblot image;
Lower panel: mean (6 SEM) values of ZIP8 band intensities standardized against b-actin band intensities. (B) Intracellular Cd2þ concentrations in HEK293 cells transfected
with the pcDNA-ZIP8-Ala391 or pcDNA-ZIP8-Thr391 plasmid, standardized against transfection efficiency and subtracted from intracellular Cd2þ concentrations of HEK293
cells transfected with the empty pcDNA3.1(þ) plasmid. Data shown are mean (6 SEM) values from three experiments, with duplicate for each plasmid in each experiment.
(C) Immunoblotting analysis of HUVECs of the Ala/Ala or Ala/Thr genotype with an anti-ZIP8 antibody and an antibody for the loading control protein Hsc-70. Upper panel:
a representative immunoblot image; lower panel: mean (6 SEM) values of ZIP8 band intensities standardized against Hsc-70 band intensities. (D) Intracellular Cd2þ concen-
trations in HUVECs of the Ala/Ala or Ala/Thr genotype, standardized against ZIP8 levels (represented by ZIP8 band intensities with normalization against b-actin band inten-
sities). Data shown are mean (6 SEM) values from 3 experiments, with duplicate for each plasmid in each experiment. * Indicates P<0.05 by paired Student’s t-test.
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To investigate if the effect of the ZIP8 Ala391-to-Thr391 sub-
stitution on NFŒB activation also existed in vascular endothelial
cells, HUVECs of either the Ala/Ala or Ala/Thr genotype were
subjected to immunoblot analysis of the IKK complex (IKKa and
IKKb), a central regulator of NFŒB activation (21). HUVECs of the
Ala/Ala genotype had a significantly larger increase in IKKa/b
phosphorylation than those of the Ala/Thr genotype, comparing
24 h with 4 h incubation with 1 lmol/l Cd2þ ( Figure 5B and C).
Discussion
In these in vitro experiments, we found that the BP-associated
SNP rs13107325 resulting in the ZIP8 Ala391-to-Thr391 substitu-
tion exerted an effect on Cd2þaccumulation in kidney and vas-
cular endothelial cells following exposure to extracellular Cd2þ,
as well as on Cd2þ-stimulated intracellular signal pathway acti-
vation and cell death. This effect is likely to arise from the
amino acid change rather than a difference in expression level,
since there was no genotype-dependent difference in the ZIP8
protein level as shown in Figure 2C. This is supported by the re-
sults of the computational analysis which indicates that the
Ala391-to-Thr391 substitution induces a structural change of
the ZIP8 protein. These results demonstrate that rs13107325 is a
functional genetic variant which can influence the survival of
kidney and vascular endothelial cells, two cell types that play
important roles, respectively, in salt-fluid homeostasis and vas-
cular tone regulation, paramount to BP control.
Chronic Cd2þexposure has been shown to increase BP in ani-
mal models (15). Furthermore, some studies in humans have
detected an association between Cd2þexposure and elevated BP
(8–10). There is evidence indicating that the effect of Cd2þon BP
is primarily due to its accumulation and toxicity in the kidney
(22). It has been reported that greater than one-third of body
Cd2þdeposits are found in the kidney, some of which are ex-
creted via the urine (23). The most common form of Cd2þ in the
blood circulation is metallothionein (MT)-bound, which is par-
tially filtered by the glomeruli, followed by reabsorption at the
proximal tubule (24). A balance of MT and Cd2þconcentration is
important for renal protection as non-MT-bound Cd2þcan be
toxic (25). Studies of mice with SLC39A8 knock-in have indicated
that ZIP8 mediates Cd2þuptake in the kidney proximal tubule
and thereby plays an important role in Cd2þ-induced nephro-
toxicity and kidney failure (3,26). In line with these literatures,
our in vitro study showed that following an incubation with
Figure 3. Effect of ZIP8 Ala391-to-Thr391 on Cd2þ-induced cell death. (A) Digital light microscopic images of HEK293 cells transfected with the pcDNA-ZIP8-Ala391,
pcDNA-ZIP8-Thr391, or pcDNA3.1(þ) plasmid, followed by a 24 h incubation with Cd2þ (1 mmol/l). (B) Percentages of viable HEK239 cells transfected with the pcDNA-
ZIP8-Ala391, pcDNA-ZIP8-Thr391, or pcDNA3.1(þ) plasmid, followed by a 2 h incubation with Cd2þ (1 mmol/l), determined by MTS assay. (C) Relative amounts of LDH in
media conditioned by HEK239 cells transfected with the pcDNA-ZIP8-Ala391, pcDNA-ZIP8-Thr391, or pcDNA3.1(þ) plasmid, followed by a 24 h incubation with Cd2þ
(1 mmol/l). (D) Relative amounts of LDH in media conditioned by HUVECs of the Ala/Ala or Ala/Thr genotype, followed by a 24 h incubation with Cd2þ (1 mmol/l). Data
shown in (B), (C) and (D) are mean (6 SEM) values from 3 experiments, with triplicate for each plasmid in each experiment. *Indicates P<0.05 by Wilcoxon test.
4121Human Molecular Genetics, 2016, Vol. 25, No. 18 |
Cd2þ, ZIP8-Ala391 expressing HEK293 cells had significantly
greater accumulation of intracellular Cd2þ, leading to higher
Cd2þ-induced cell death compared with ZIP8-Thr391 expressing
cells. This provides a possible mechanistic explanation for the
association between the ZIP8-Ala391 allele and increased BP re-
vealed by GWAS (3).
There is evidence indicating that the effect of Cd2þon blood
pressure is, to some extent, also due to Cd2þ-induced vascular
endothelial cell damage and dysfunction. Cd2þcan cause vaso-
constriction by inhibiting nitric oxide (14), increasing endothe-
lial permeability (16), promoting peroxidation of membrane
lipids (27), and inducing endothelial cell death (17). These can
Figure 4. Effect of ZIP8 Ala391-to-Thr391 on ERK phosphorylation in cells incubated with Cd2þ. HEK239 cells transfected with the pcDNA-ZIP8-Ala391, pcDNA-ZIP8-
Thr391, or pcDNA3.1(þ) plasmid, were incubated with Cd2þ (1 mmolL) for 24 h, followed by immunoblotting analyses of ZIP8, total ERK1, phosphorylated ERK1, total
ERK2, and phosphorylated ERK2. (A) Representative immunoblot images. (B) Mean (6 SEM) values of relative intensities of the ZIP8 band. (C) Mean (6 SEM) values of
the ratio of phosphorylated ERK1 band intensity versus total ERK1 band intensity, standardized against ZIP8 band intensity. (D) Mean (6 SEM values of the ratio of
phosphorylated ERK2 band intensity versus total ERK2 band intensity, standardized against ZIP8 band intensity. Data shown in (B) to (D) are from three experiments,
with triplicate for each plasmid in each experiment. * Indicates P< 0.05 by paired Student’s t-test.
Figure 5. Effect of ZIP8 Ala391-to-Thr391 on NFjB activity in cells incubated with Cd2þ. (A) HEK293 cells were transfected with either the pcDNA-ZIP8-Ala391, pcDNA-ZIP8-
Thr391, or pcDNA3.1(þ) plasmid, as well as a firefly luciferase reporter plasmid containing copies of the NFjB responsive element upstream of the firefly luciferase reporter
gene, and a renilla luciferase plasmid to serve a reference for transfection efficiency. The transfected cells were incubated with Cd2þ (1lmol/l) for 2 h, and NFjB activity mea-
sured by dual-luciferase assays. Data shown are mean (6 SEM) luciferase activity from three experiments, with triplicate for each plasmid in each experiment. (B) HUVECs
of the Ala/Ala or Ala/Thr genotype were subjected to immunoblotting analyses of the phospho-IKKa/b. Shown on the left is a representative immunoblot image, and on the
right are the relative phospho-IKKa/b band intensities standardized against loading control protein (Hsc-70) band intensities in different genotypes. Data shown are mean
(6SEM) values from 3 experiments of 4 samples for each genotype, conducted in duplicate. * Indicates P<0.05 by paired Student’s t-test.
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promote atherosclerosis, a risk factor for hypertension (28). In
agreement, other studies have demonstrated that Cd2þ-fed
apoE-/- mice have significantly larger atherosclerotic plaques
(17,29). Furthermore, epidemiological studies have shown that
elevation in blood Cd2þ level is independently associated with
early atherosclerotic vessel wall thickening in healthy female
individuals and that there is increased frequency of atheroscle-
rosis in a Cd2þcontaminated area in the Netherlands (11,17). In
the present study, we found that vascular endothelial cells of
the rs13107325 Ala/Ala genotype had higher Cd2þuptake and
were more susceptible to Cd2þ-induced cell death than cells of
Ala/Thr genotype. This provides another possible mechanistic
explanation for the association between the ZIP8-Ala391 allele
and increased BP (3).
The cytotoxic effect of Cd2þhas previously been shown to be
mediated by the ERK signalling pathway (30). Upon activation,
phosphorylated ERK1/2 can enter the nucleus and phosphory-
late transcription factors involved in cell-cycle regulation (31).
A growing body of evidence suggests that aberrant activation of
ERK can promote cell death (30,32). It has been reported that in
HEK293 cells, sustained ERK activation can last up to 6 days fol-
lowing Cd2þexposure (33). In the present study, we found that
Cd2þ-induced ERK activation was greater in ZIP8-Ala391 ex-
pressing cells than in ZIP8-Thr391 expressing cells. This sug-
gests that the greater cytotoxic effect of Cd2þ in ZIP8-Ala391
expressing cells (comparing to ZIP8-Thr391 expressing cells) is
in part mediated by a greater ERK activation.
The transcription factor NFjB regulates the expression of
many genes with various cellular functions (34,35). Previous
studies have demonstrated an association of Cd2þ-induced apo-
ptosis with NFjB activation, and trans-activation of anti-
apoptotic and/or survival genes, oxidative stress-related genes
and inflammatory cytokines (34,36–38). In the present study, we
found that NFjB activity was significantly higher in ZIP8-Ala391
expressing cells compared to ZIP8-Thr391 expressing cells fol-
lowing Cd2þ treatment. We also detected higher levels of the
NFŒB effector elements phospho-IKKa/b in HUVECs of the Ala/
Ala genotype when compared with HUVECs of the Ala/Thr ge-
notype. Therefore, these experiments demonstrate that cells
carrying the ZIP8-Ala391 allele had higher levels of NFjB activa-
tion in response to Cd2þexposure, possibly to counteract cell
death.
Interestingly, in addition to its relation with BP, rs13107325
has been shown to be associated with a number of other traits
and disorders, including blood levels of N-terminal pro-B-type
natriuretic peptide levels (39), manganese (40), total cholesterol
(41), high density lipoprotein (41–43) and triglyceride levels (41),
as well as height (41), body mass index (44), schizophrenia
(41,45) and Parkinson’s disease (41), among others (41).
Therefore, rs13107325 appears to have pleiotropic effects and it
is possible that its influence on BP may involve more than one
intermediary pathway. Conversely, the results of our study
showing an effect of rs13107325 on Cd2þ-induced cell toxicity
also provide a possible explanation for the association of this
SNP with some other diseases such as schizophrenia and
Parkinson’s disease which have been suggestively linked with
Cd2þexposure (46,47).
There are some limitations to our study. First, the study was
conducted using human cell models in vitro. Future studies us-
ing in vivo models are warranted. It has been reported that
global SLC39A8 (-/-) knockout mice were embryonically lethal
(48). Therefore, one possibility would be to test the possible ef-
fect of conditional knockout, knockdown or knock-in of
SLC39A8 on BP in mice with and without Cd2þexposure (48,49).
Second, our study focused on the effect of Cd2þ. Further studies
to examine possible influences of other metal ions transported
by ZIP8, for example Zn2þand Mn2þ, would also be warranted.
In conclusion, the results of this study demonstrate that the
BP-associated SNP rs13107325 has a functional effect on ZIP8
which can influence the viability of kidney and vascular endo-
thelial cells. These findings can contribute to a better under-
standing of the functional roles of genetic variants in BP
regulation, which in turn can facilitate the development of new
therapeutics for hypertension.
Materials and Methods
Structural prediction
Human ZIP8 protein sequences were retrieved from Ensembl
version 78 (51). The longest isoform (ENST00000356736), deemed
as canonical, was chosen for further analysis. Conservation
analysis was performed on Ensembl using 23 way alignment of
high-coverage amniote vertebrate genomes. The ConSurf server
was used to predict functional domains based on the evolution-
ary conservation of amino acid positions, with UniRef protein
clusters to infer the phylogenetic relations between homolo-
gous sequences (52). The Robetta approach was employed to
predict the secondary structure of ZIP8–Ala391 and ZIP8-Thr391
(53). This method segments the protein into domains that are
homologous to proteins with known structure, before an op-
tional structure refinement procedure. The domain containing
amino acid 391 for both versions of the protein was fully pro-
cessed and analysed using PyMol to assess the predicted struc-
tural effects of the amino acid substitution in the respective
functional domain (54). Further to the full structural reconstruc-
tion, prediction of Transmembrane Helices in proteins
(TMHMM) v2 program was used to predict transmembrane heli-
cal domains within the input sequences (55).
Cell culture
HUVECs were isolated from umbilical cords from different indi-
viduals (n¼ 178) using a standard procedure (50). Cords from
miscarriages, stillbirths, or HIV positive, group B streptococcus
positive or hepatitis B infected mothers were excluded. Cells
were maintained in M199 medium (Sigma, M4530) supple-
mented with 15% foetal bovine serum (Appleton Woods, FB021),
L-glutamine, 2.5 lg/ml b-endothelial growth factor (Sigma,
E1388), 4.5 lg/ml endothelial cell growth factor (Sigma, E2759),
2.5 lg/ml thymidine (Sigma, 89270), heparin (Sigma, H3393), and
1% penicillin/streptomycin. Cells of passage4 were used for
the experiments in this study. HEK293 cells were maintained in
DMEM medium (Sigma, D5796) supplemented with 10% foetal
bovine serum, 3.34 mM/l L-glutamine, 0.02 units/l penicillin and
20 mg/l streptomycin.
Genotyping
Genomic DNA extracted from HUVECs was genotyped for
rs13107325 with the use of TaqMan SNP genotyping assay
(Applied Biosystems, c_1827682_10). Genotyping results of a
subset of samples were verified by DNA sequencing.
Construction of ZIP8 expression plasmids
Full-length human SLC39A8 cDNA (GenBank Accession No.
NM_022154.5) in pCMV6-XL4 plasmid was purchased from
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OriGene (Origene, SC112817). The cDNA, corresponding to the C
allele for SNP rs13107325 and therefore encoding the Ala391 form
of ZIP8, was cloned into pcDNA3.1(þ) expression plasmid. Using
this plasmid (pcDNA-ZIP8-Ala391) as a template, site-directed
mutagenesis was carried out to generate a plasmid (pcDNA-ZIP8-
Thr391) in which the nucleotide C at the rs13107325 site in the
SLC39A8 cDNA was changed to T. The DNA sequences of both
plasmids were verified to be correct by sequencing.
Cd2þ transport assay
HEK293 cells were transfected with either pcDNA-ZIP8-Ala391,
pcDNA-ZIP8-Thr391, or the pcDNA3.1(þ) plasmid, by the calcium
phosphate transfection method. Transfected HEK293 cells, and
untransfected HUVECs of different genotypes for SNP rs13107325,
were subjected to Cd2þ transport assays. In brief, cells were cul-
tured in normal medium to 80–85% confluency and then in
serum-free medium containing 1mM (0.2% v/v in H2O) CdCl2
(Sigma, 439800) for 2 or 24 h. Thereafter, cells were washed with
phosphate buffered saline, and then the cell lysates prepared in
lysis buffer consisting of 150 mM NaCl, 50 mM Tris 7.5, 1% Nonidet
P40, 0.5% sodium deoxycholate, and 1x protease inhibitors.
Cd2þconcentrations in the cell lysates were determined using
Measure-iTTM cadmium assay kit (Invitrogen, M36353), according
to manufacturer’s instructions. The fluorescence intensity
indicating Cd2þcontent was recorded for each well at 520 nm
(kex: 490 nm), with two readings for each sample. The
Cd2þconcentration values were extrapolated from a standard
curve ranging from 0 to 4.2mM. In the HEK293 cell assays,
Cd2þvalues from cells transfected with either the pcDNA-ZIP8-
Ala391 or pcDNA-ZIP8-Thr391 plasmid were standardized for ZIP8
protein levels determined by immunoblot analysis and subtracted
by those from cells transfected with the pcDNA3.1(þ) plasmid.
Cell viability assay
Cytotoxicity induced by Cd2þexposure was assessed in trans-
fected HEK293 cells and in untransfected HUVECs of different
genotypes. Following incubation of cells with 1 lmol/l Cd2þ for
24 h, cell morphological changes were assessed by microscopic
examination, and the percentages of viable cells were deter-
mined with the use of CellTiter 96 AQueous One Solution Cell
Proliferation Assay kit (Promega, G3582, or being referred to as
MTS) using the following equation:
ðAb490nm in cadmium treated cellsÞ  ðAb490nm in mediaÞ
ðAb490nm in untreated cellsÞ  ðAb490nm in mediaÞ 100%
The lactate dehydrogenase (LDH) released from dead cells
into culture media was measured using a lactate dehydroge-
nase assay kit (Pierce Thermo, 88953) as per the manufacturer’s
instructions, and the amounts of LDH in the media were calcu-
lated using the following equation:
ðLDH activity in media of cadmium treated cellsÞ
ðLDH activity in media of untreated cellsÞ
ðLDH activity in media and lysates of untreated cellsÞ
ðLDH activity in media of untreated cellsÞ
100%
Immunoblotting analyses
Total cell lysates were prepared from transfected HEK293 cells
and from HUVECs. Protein concentrations in the lysates were
measured by the bicinchoninic acid assay (Pierce, 23227).
To determine the relative amounts of ZIP8, 15 lg total cellular
proteins from each sample were subjected to standard immu-
noblotting analysis with an anti-ZIP8 antibody (Abcam,
ab103182) and subsequently with an anti-b-actin (Abcam,
ab8226) or anti-Hsc70 (Santa Cruz, sc7298) antibody as a loading
control. To determine the relative quantities of total and phos-
phorylated ERK1/2, 15 lg proteins from each sample were ana-
lysed by immunoblotting with an antibody for phospho-p44/42
MAPK (ERK1/2)(Cell Signalling, 9101) and an antibody for total
p44/42 MAPK (Cell Signalling, 9102). The blots were subjected to
densitometric analysis with GIMP 2.8.16 software. The relative
protein levels were standardized against the levels of the load-
ing control protein.
Luciferase reporter assay
Using X-tremeGENE HP DNA transfection system (Roche,
06366236001), HEK293 cells were transfected with a ZIP8 expres-
sion plasmid (pcDNA-ZIP-Ala391 or pcDNA-ZIP-Thr391), a firefly
luciferase reporter plasmid containing copies of the NFjB re-
sponsive element upstream of the firefly luciferase reporter
gene, and a renilla luciferase plasmid to serve as a reference for
transfection efficiency. Twenty-four hours after transfection,
cells were incubated with 1 lmol/l Cd2þ for a further 2 h before
being analysed using a dual luciferase assay kit (Promega,
E1910). The NFjB activity was calculated by the ratio of the lu-
minescence intensity yielded by firefly luciferase versus that by
renilla luciferase.
Statistical analyses
Paired Student’s t-tests were performed for variables with nor-
mal distribution, and Wilcoxon matched-pairs test was used for
variables not in normal distribution. Data are presented as
mean6SEM from at least three independent experiments, and
all p values are two-tailed.
Supplementary Material
Supplementary Material is available at HMG online.
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